Free Trial

Tectonic Therapeutic (TECX) Competitors

Tectonic Therapeutic logo
$26.18 +0.78 (+3.07%)
Closing price 04:00 PM Eastern
Extended Trading
$26.15 -0.03 (-0.11%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TECX vs. DYN, IMCR, SPRY, TVTX, CDTX, AUPH, JANX, AMPH, EWTX, and SDGR

Should you be buying Tectonic Therapeutic stock or one of its competitors? The main competitors of Tectonic Therapeutic include Dyne Therapeutics (DYN), Immunocore (IMCR), ARS Pharmaceuticals (SPRY), Travere Therapeutics (TVTX), Cidara Therapeutics (CDTX), Aurinia Pharmaceuticals (AUPH), Janux Therapeutics (JANX), Amphastar Pharmaceuticals (AMPH), Edgewise Therapeutics (EWTX), and Schrodinger (SDGR). These companies are all part of the "pharmaceutical products" industry.

Tectonic Therapeutic vs. Its Competitors

Dyne Therapeutics (NASDAQ:DYN) and Tectonic Therapeutic (NASDAQ:TECX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

Dyne Therapeutics has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Tectonic Therapeutic has a beta of 3.27, meaning that its stock price is 227% more volatile than the S&P 500.

Tectonic Therapeutic is trading at a lower price-to-earnings ratio than Dyne Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dyne TherapeuticsN/AN/A-$317.42M-$3.86-3.26
Tectonic TherapeuticN/AN/A-$57.98M-$4.04-6.48

In the previous week, Dyne Therapeutics had 4 more articles in the media than Tectonic Therapeutic. MarketBeat recorded 6 mentions for Dyne Therapeutics and 2 mentions for Tectonic Therapeutic. Tectonic Therapeutic's average media sentiment score of 1.69 beat Dyne Therapeutics' score of 0.67 indicating that Tectonic Therapeutic is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Dyne Therapeutics
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tectonic Therapeutic
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

96.7% of Dyne Therapeutics shares are owned by institutional investors. Comparatively, 62.6% of Tectonic Therapeutic shares are owned by institutional investors. 14.1% of Dyne Therapeutics shares are owned by company insiders. Comparatively, 38.0% of Tectonic Therapeutic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Tectonic Therapeutic's return on equity of -30.13% beat Dyne Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Dyne TherapeuticsN/A -64.12% -56.75%
Tectonic Therapeutic N/A -30.13%-28.33%

Dyne Therapeutics currently has a consensus price target of $33.80, indicating a potential upside of 168.68%. Tectonic Therapeutic has a consensus price target of $80.33, indicating a potential upside of 206.85%. Given Tectonic Therapeutic's stronger consensus rating and higher possible upside, analysts clearly believe Tectonic Therapeutic is more favorable than Dyne Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dyne Therapeutics
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
3.00
Tectonic Therapeutic
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

Summary

Tectonic Therapeutic beats Dyne Therapeutics on 8 of the 14 factors compared between the two stocks.

Get Tectonic Therapeutic News Delivered to You Automatically

Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TECX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TECX vs. The Competition

MetricTectonic TherapeuticMED IndustryMedical SectorNASDAQ Exchange
Market Cap$489.83M$3.09B$5.83B$9.73B
Dividend YieldN/A2.23%3.84%4.09%
P/E Ratio-6.4821.1631.1625.99
Price / SalesN/A396.94474.86122.97
Price / CashN/A43.0937.1558.38
Price / Book1.738.069.116.38
Net Income-$57.98M-$54.72M$3.26B$265.56M
7 Day Performance11.36%2.52%2.06%1.89%
1 Month Performance17.82%7.54%5.08%1.23%
1 Year Performance52.21%13.01%31.26%21.10%

Tectonic Therapeutic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TECX
Tectonic Therapeutic
2.73 of 5 stars
$26.18
+3.1%
$80.33
+206.9%
+56.3%$489.83MN/A-6.48120Positive News
DYN
Dyne Therapeutics
3.2983 of 5 stars
$11.54
+2.6%
$34.94
+202.8%
-74.0%$1.64BN/A-2.99100
IMCR
Immunocore
1.851 of 5 stars
$32.15
+0.8%
$58.00
+80.4%
-10.6%$1.61B$310.20M-80.34320Positive News
SPRY
ARS Pharmaceuticals
2.7275 of 5 stars
$16.24
-0.8%
$31.00
+90.9%
+11.0%$1.59B$89.15M-101.3190Insider Trade
TVTX
Travere Therapeutics
2.4499 of 5 stars
$17.58
+1.7%
$32.21
+83.2%
+104.7%$1.57B$233.18M-8.61460
CDTX
Cidara Therapeutics
3.607 of 5 stars
$62.08
+0.1%
$64.14
+3.3%
+419.2%$1.56B$1.27M-5.5390
AUPH
Aurinia Pharmaceuticals
2.7024 of 5 stars
$11.40
-0.3%
$12.00
+5.3%
+83.3%$1.50B$235.13M26.58300Positive News
JANX
Janux Therapeutics
2.1306 of 5 stars
$23.95
+5.6%
$91.89
+283.7%
-46.5%$1.43B$10.59M-13.2630
AMPH
Amphastar Pharmaceuticals
3.2976 of 5 stars
$30.53
+11.6%
$31.50
+3.2%
-36.7%$1.41B$731.97M11.392,028
EWTX
Edgewise Therapeutics
2.3662 of 5 stars
$13.52
+4.0%
$41.60
+207.8%
-30.2%$1.41BN/A-8.6660Analyst Forecast
SDGR
Schrodinger
3.0987 of 5 stars
$18.77
+0.8%
$32.75
+74.5%
-2.5%$1.38B$207.54M-7.57790

Related Companies and Tools


This page (NASDAQ:TECX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners